Our Proven Strategy
At Agent Capital, we have a balanced investment approach and a deep understanding of pipeline pressures in healthcare.
We participate in a wide range of financing rounds:

Early Stage Financings
(e.g., Seed investment, First Institutional Round)

Later Stage Financings
(e.g., Post-Series A, Crossover, PIPEs)
We have a primary focus on therapeutic areas with high, unmet medical need, including:

Rare Diseases

Oncology

Neurology

Immunology
×
We have a systematic approach to selecting and supporting each investment:
- Invest alongside other likeminded investors
- Lead or co-lead financing rounds
- Support experienced entrepreneurs and management teams
- Guide companies to milestones and exits
- Connect portfolio companies to our wide Pharma network of executives